By NewsDesk  @bactiman63 Gilead Sciences, Inc. today announced the U.S. Food and Drug Administration (FDA) approved a new low-dose tablet dosage form of Biktarvy® (bictegravir 30 mg/emtricitabine 120...

Merck and Ridgeback Biotherapeutics announced recently that molnupiravir (MK-4482, EIDD-2801), an investigational oral antiviral medicine, significantly reduced the risk of hospitalization or death at...

By NewsDesk  @infectiousdiseasenews From a press release from Juntendo University in Bunkyo City, Tokyo (computer translated): Malaria is transmitted from person to person through mosquitoes and causes...

By NewsDesk  @infectiousdiseasenews Recently, the Utah Department of Health became aware of a patient who ingested large doses of ivermectin in an attempt to treat symptoms of COVID-19. The patient suffered...

NewsDesk  @infectiousdiseasenews As the threat of resistance to current malaria treatment grows, Novartis and MMV have reported positive results of a new non-artemisinin combination in a Phase 2b study. The...

NewsDesk  @infectiousdiseasenews Last Wednesday, New Mexico state health officials announced during a COVID-19 update the deaths of two people linked to taking the anti-parasitic drug, ivermectin for...

By NewsDesk  @infectiousdiseasenews A treatment combining two antibodies (casirivimab and imdevimab) is recommended for two specific groups of patients with covid-19 by a WHO Guideline Development Group...

NewsDesk  @infectiousdiseasenews A new Cornell study has found the antimicrobial properties of certain stem cell proteins could offer a potential treatment to reduce infection in skin wounds. Treating...

NewsDesk  @infectiousdiseasenews Australia’s Therapeutic Goods Administration (TGA) placed new restrictions on the prescribing of oral ivermectin, according to an announcement last Friday. General...

NewsDesk  @infectiousdiseasenews the customs units of the Ministry of Health which are responsible for the evaluation of specific requests for the importation of medicines from abroad, the Italian Medicines...